Results 171 to 180 of about 1,491,973 (279)
The Role of Extended Reality in Orthodontic Treatment Planning and Simulation-A scoping Review. [PDF]
Marya A +5 more
europepmc +1 more source
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu +8 more
wiley +1 more source
Transforming Care in Congenital Heart Disease: The Role of Extended Reality in Family and Trainee Education and Procedural Planning. [PDF]
Gunsaulus M +6 more
europepmc +1 more source
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha +4 more
wiley +1 more source
UnitedXR Europe 2025: Aligning Health Care Extended Reality.
Costa JF.
europepmc +1 more source
Applications of extended reality in pilot flight simulator training: a systematic review with meta-analysis. [PDF]
Somerville A, Joiner K, Lynar T, Wild G.
europepmc +1 more source
ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef +2 more
wiley +1 more source
Advancing Digital Access to Physical Therapy via Virtual and Extended Reality Technology: Prototype Development and Usability Evaluation. [PDF]
Tiase VL +9 more
europepmc +1 more source
Bora Bağış, Duygu K Arpaçay
openaire +1 more source
Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham +7 more
wiley +1 more source

